2017 WL 2964811
Ct. Int'l Trade2017Background
- CannaKorp requested a CBP pre‑importation ruling in April 2016 about whether its CannaCloud vaporizer pod system is exempt from the CSA’s drug‑paraphernalia import prohibition under 21 U.S.C. § 863(f)(1).
- CBP issued a ruling on March 24, 2017 concluding the CannaCloud is not exempt and may not be lawfully imported.
- CannaKorp filed suit in the U.S. Court of International Trade invoking 28 U.S.C. § 1581(h) for pre‑importation review and sought expedited proceedings and fees.
- Jurisdiction under § 1581(h) requires showing (inter alia) that irreparable harm will occur absent pre‑importation review; the parties contested only that fourth prong.
- CannaKorp relied on two CEO declarations alleging imminent business disruption, financial loss, and reputational harm; it provided no financial records, contracts, or third‑party affidavits.
- The court held CannaKorp failed to prove irreparable harm by clear and convincing evidence, dismissed for lack of subject‑matter jurisdiction, and denied expedited relief as moot.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether CIT has jurisdiction under 28 U.S.C. § 1581(h) (irreparable‑harm requirement) | CannaKorp: CBP ruling imminently threatens company survival via lost suppliers, funding, employees, and first‑mover advantage; monetary relief may be unrecoverable due to sovereign immunity. | U.S.: Alleged harms are speculative, self‑inflicted, unsupported by evidence, and thus fail the clear‑and‑convincing irreparable‑harm standard. | Court: No jurisdiction — plaintiff did not prove irreparable harm by clear and convincing evidence; case dismissed. |
| Whether CEO declarations suffice to prove imminence and magnitude of harm | CannaKorp: CEO declarations describe imminent loss of revenue, supplier relationships, and need to raise $10M; additional fundraising difficulty due to CBP ruling. | U.S.: Declarations are inconsistent, vague, conditional, and uncorroborated; absence of business plans, contracts, or financials prevents evaluation. | Court: Declarations insufficiently specific and corroborated; cannot meet heightened burden. |
| Whether alleged economic harms are irreparable because monetary relief may be unavailable | CannaKorp: Sovereign immunity could make monetary recovery impossible, rendering harms irreparable. | U.S.: Plaintiff first must prove the harms; unrecoverability does not relieve burden of proof. | Court: Because harms were not proved, court did not reach recoverability; unrecoverability alone insufficient to satisfy § 1581(h). |
| Whether litigation expense and delay constitute irreparable harm | CannaKorp: Time and costs of litigation are harms related to delay. | U.S.: Litigation expense is ordinary and not irreparable. | Court: Litigation costs do not constitute irreparable harm. |
Key Cases Cited
- Steel Co. v. Citizens for a Better Env’t, 523 U.S. 83 (jurisdictional requirement must be resolved before merits)
- Arbaugh v. Y & H Corp., 546 U.S. 500 (if court lacks subject‑matter jurisdiction complaint must be dismissed)
- Cedars–Sinai Medical Ctr. v. Watkins, 11 F.3d 1573 (when jurisdictional facts are controverted court may resolve by fact‑finding)
- Waits v. Frito‑Lay, 978 F.2d 1093 (irreparable‑harm standard for injunctions; harm must be highly probable)
- Wisc. Gas Co. v. FERC, 758 F.2d 669 (business‑ending economic loss may be irreparable)
- Celsis In Vitro, Inc. v. CellzDirect, Inc., 664 F.3d 922 (examples of reputational and market harms relevant to irreparable‑harm analysis)
- Zenith Radio Corp. v. United States, 710 F.2d 806 (present, actual threat required; mere possibility insufficient)